Category: Combined Treatment: News, Information & Studies
Dendritic Cell-Based Immunotherapy in Patients with Resected Pancreatic Cancer: A Promising Strategy for Preventing Recurrence
Discover the promising potential of dendritic cell-based immunotherapy for preventing recurrence in patients with resected pancreatic cancer. A groundbreaking phase I/II clinical trial demonstrates that this immunotherapy approach significantly improves
Improved Survival in Stage IV Breast Cancer with DCT
The study aimed to assess the impact of immunotherapy in 368 patients with stage IV breast cancer. The patients were divided into two groups: one receiving a combination of DC-CIK
Combining DCT with Chemotherapy in Metastatic Prostate Cancer: Phase I/II Clinical Trial
In this study, researchers present the results of a Phase I/II clinical trial conducted on patients with metastatic castration-resistant prostate cancer (mCRPC). The trial focused on a novel approach using
Effective Drug Combinations for Melanoma: High-Throughput Screening Success
Discover the groundbreaking work in developing and validating growth inhibition assays for patient-derived melanoma cell lines, both with and without BRAF mutations.
the Power of Combination Radio-Immunotherapy Against Immunologically Cold Neuroblastoma
Most pediatric tumors are considered "cold" and don't respond well to immune checkpoint inhibition. However, hope is on the horizon with the discovery of CAIR, a combination radio-immunotherapy treatment. This
